Guizhou Sanli Pharmaceutical Co., Ltd. Class ASSE: 603439

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026

Aug 28, 2026 · Issued by Guizhou Sanli Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Guizhou Sanli Pharmaceutical Co., Ltd. Class A

"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual ReportJul 24
"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive PlanJul 22
"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Expected Decrease in Semi-annual Performance for 2026Jul 15
"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Pledging Partial Shares of Person Acting in Concert of Controlling ShareholderJul 3

All Guizhou Sanli Pharmaceutical Co., Ltd. Class A news releases